Claudin-1 製品リスト
You Have Viewed 0 Of 0 Results
治験薬に関する情報
| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Monalizumab | NN-8765; IPH-2201; NNC-0141-0000-0100 | Phase 3 Clinical | Innate Pharma, Novo Nordisk A/S | Breast Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Esophageal Squamous Cell Carcinoma; Mouth Neoplasms; Carcinoma, Squamous Cell; Esophageal adenocarcinoma; Inflammation; Genital Neoplasms, Female; Colorectal Neoplasms; Head and Neck Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Transitional Cell; Small Cell Lung Carcinoma; Arthritis, Rheumatoid; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Hematologic Neoplasms; Solid tumours | 詳細 |
| BMS-986315 | BMS-986315 | Phase 2 Clinical | Bristol-Myers Squibb Company | Solid tumours; Carcinoma, Non-Small-Cell Lung | 詳細 |
| S-095029 | S-095029 | Phase 2 Clinical | Institut De Recherches Internationales Servier | Solid tumours; Esophageal Neoplasms; Mismatch Repair Deficient Cancer; Stomach Neoplasms; Microsatellite instability-high cancer; Carcinoma, Non-Small-Cell Lung | 詳細 |
| BRY-805 | BRY805; BRY-805 | Phase 1 Clinical | BioRay Pharmaceutical Co Ltd | Solid tumours | 詳細 |
| HY000102 | HY-0102; HY-000102 | Phase 1 Clinical | Shanghai HyaMab Biotech Co Ltd | Solid tumours; Pancreatic Neoplasms | 詳細 |